Showing results (331-340 of 546) with videos related to
Sort By:
Pageof 55
Diagnostics (Basel, Switzerland)|January 8, 2025
Fully Automated Assessment of Cardiac Chamber Volumes and Myocardial Mass on Non-Contrast Chest CT with a Deep Learning Model: Validation Against Cardiac MRRamona Schmitt, Christopher L Schlett, Jonathan I Sperl, et al.European Journal of Pharmacology|November 23, 2006
Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditisJun Li, Sebastian Leschka, Susanne Rutschow, et al.Journal of Tissue Engineering and Regenerative Medicine|June 11, 2022
Human cardiac organoids to model COVID-19 cytokine storm induced cardiac injuriesDimitrios C Arhontoulis, Charles M Kerr, Dylan Richards, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 24, 2021
Heyde syndrome: prevalence and outcomes in patients undergoing transcatheter aortic valve implantationLara Waldschmidt, Andreas Drolz, Paula Heimburg, et al.European Heart Journal|October 12, 2017
Discrimination of patients with type 2 myocardial infarctionJohannes Tobias Neumann, Nils Arne Sörensen, Nicole Rübsamen, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 1, 2019
Transcatheter aortic valve implantation versus surgical aortic valve replacement in low-risk patients: a propensity score-matched analysisAndreas Schaefer, Niklas Schofer, Alina Goßling, et al.Biomolecules|September 12, 2019
Prognostic Value of a Novel and Established High-Sensitivity Troponin I Assay in Patients Presenting with Suspected Myocardial InfarctionNils A Sörensen, Sebastian Ludwig, Nataliya Makarova, et al.Cardiovascular Research|February 7, 2012
Thrombospondin-2 prevents cardiac injury and dysfunction in viral myocarditis through the activation of regulatory T-cellsAnna-Pia Papageorgiou, Melissa Swinnen, Davy Vanhoutte, et al.Circulation. Heart Failure|November 16, 2010
Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fractionDirk Westermann, Diana Lindner, Mario Kasner, et al.European Journal of Heart Failure|March 7, 2008
Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in miceAlexander Riad, Sandra Bien, Matthias Gratz, et al.Pageof 55